|
KD702a : Multiple kidney cancer with matched tumor adjacent (AT) kidney tissue array, 35 cases/70 cores, including CCRCC (15 cases), PRCC (9 cases), CHRCC (8 cases), ccpRCC (3 cases)
Description
| Microarray Panel |
Multiple kidney carcinoma with match kidney tissue microarray, containing 35 cases of kidney carcinoma (15 clear cell renal cell carcinoma, 9 papillary renal cell carcinoma, 3 clear cell papillary renal cell carcinoma, 8 chromophobe renal carcinoma), and matched cancer adjacent or adjacent normal kidney tissue, duplicated cores per case |
| Cores |
70 |
|
| Cases |
35 |
| Row number |
7 |
| Column number |
10 |
| Core Diameter (mm) |
2 |
| Thickness (µm) |
5 |
| Quality Control |
H&E and IHC confirmed |
| Tissue Array Type |
FFPE |
| Species |
Human |
| Applications |
5Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.Price |
| Notes |
1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers. |
Mouseover and click individual cores to view high resolution images.
Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Find overlapping cases with this tissue array:
- Product Code: KD702a
- Availability: In Stock
|
Tags:
With normal control,
With adjacent normal,
Duplicate cores per case,
Stage (TNM)
- AT,
- Malignant tumor,
- Malignant tumor (stage I),
- Malignant tumor (stage II),
- Malignant tumor (stage III),
- NAT